HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walgreen S&E

This article was originally published in The Rose Sheet

Executive Summary

Price reductions on thousands of cosmetics, as well as on skin care and vitamins, have been well received by consumers, retailer announces during 11first quarter sales and earnings release issued Jan. 3. Walgreens cut cosmetic prices between 5%-20% last spring. First quarter (ended Nov. 30) sales increase 16.8% to $6.6 bil., and comparable store sales were up 10.7% in the quarter. Net earnings grew 17.4% to $185.9 mil. during the period including a $5.5 mil. gain for partial payment of antitrust litigation settlement. Company plans to move forward with expansion, including 14,000 new jobs, 475 new stores and two new distribution facilities in 2002...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel